These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16989826)

  • 1. Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness.
    Luisi S; Borges LE; Lazzeri L; Dell'Anna A; Severi FM; Petraglia F
    Fertil Steril; 2006 Nov; 86(5):1483-7. PubMed ID: 16989826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
    Buckler HM; Evans CA; Mamtora H; Burger HG; Anderson DC
    J Clin Endocrinol Metab; 1991 Jan; 72(1):116-24. PubMed ID: 1824706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
    Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
    Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
    Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.
    Kallio S; Puurunen J; Ruokonen A; Vaskivuo T; Piltonen T; Tapanainen JS
    Fertil Steril; 2013 Apr; 99(5):1305-10. PubMed ID: 23260855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception.
    Croxatto HB; Brache V; Massai R; Alvarez F; Forcelledo ML; Pavez M; Cochon L; Salvatierra AM; Faundes A
    Contraception; 2006 Jan; 73(1):46-52. PubMed ID: 16371294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle.
    Duijkers IJ; Verhoeven CH; Dieben TO; Klipping C
    Hum Reprod; 2004 Nov; 19(11):2674-9. PubMed ID: 15319379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles.
    Klein NA; Illingworth PJ; Groome NP; McNeilly AS; Battaglia DE; Soules MR
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2742-5. PubMed ID: 8675606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium.
    Lüdicke F; Johannisson E; Helmerhorst FM; Campana A; Foidart J; Heithecker R
    Fertil Steril; 2001 Jul; 76(1):102-7. PubMed ID: 11438327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens.
    Vandever MA; Kuehl TJ; Sulak PJ; Witt I; Coffee A; Wincek TJ; Reape KZ
    Contraception; 2008 Mar; 77(3):162-70. PubMed ID: 18279685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
    Andersson AM; Juul A; Petersen JH; Müller J; Groome NP; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
    Hohmann FP; Laven JS; de Jong FH; Fauser BC
    Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route.
    Devoto L; Fuentes A; Palomino A; Espinoza A; Kohen P; Ranta S; von Hertzen H
    Fertil Steril; 2005 Jul; 84(1):46-51. PubMed ID: 16009156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sensitivity to steroid-negative feedback during breast-feeding: low-dose estradiol (transdermal estradiol supplementation) suppresses gonadotropins and ovarian activity assessed by inhibin B.
    Perheentupa A; Critchley HO; Illingworth PJ; McNeilly AS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4280-6. PubMed ID: 11095468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vaginal and oral administration of emergency contraception.
    Mor E; Saadat P; Kives S; White E; Reid RL; Paulson RJ; Stanczyk FZ
    Fertil Steril; 2005 Jul; 84(1):40-5. PubMed ID: 16009155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
    Baerwald AR; Olatunbosun OA; Pierson RA
    Contraception; 2004 Nov; 70(5):371-7. PubMed ID: 15504375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
    Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women.
    Reame NE; Wyman TL; Phillips DJ; de Kretser DM; Padmanabhan V
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3302-7. PubMed ID: 9745445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.